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Abstract
Background: “Determined, Resilient, AIDS-free, Mentored and Safe” (DREAMS) is a package of biomedical, social
and economic interventions offered to adolescent girls and young women aged 10–24 years with the aim of
reducing HIV incidence. In four of the six DREAMS districts in Zimbabwe, DREAMS includes an offer of oral pre-
exposure prophylaxis (DREAMS+PrEP), alongside interventions to support demand and adherence, to women aged
18–24 who are at highest risk of HIV infection, including young women who sell sex (YWSS). This evaluation study
addresses the question: does the delivery of DREAMS+PrEP through various providers reduce HIV incidence among
YWSS Zimbabwe? We describe our approach to designing a rigorous study to assess whether DREAMS+PrEP had
an impact on HIV incidence.
Methods: The study design needed to account for the fact that: 1) DREAMS+PrEP was non-randomly allocated; 2)
there is no sampling frame for the target population for the evaluation; 3) there are a small number of DREAMS
districts (N = 6), and 4) DREAMS+PrEP is being implemented by various providers. The study will use a cohort analysis
approach to compare HIV incidence among YWSS in two DREAMS+PrEP districts to HIV incidence among YWSS in
non-DREAMS comparison sites. YWSS will be referred to services and recruited into the cohort through a network-
based (respondent-driven) recruitment strategy, and followed-up 12- and 24-months after enrolment. Women will be
asked to complete a questionnaire and offered HIV testing. Additional complications of this study include identifying
comparable populations of YWSS in the DREAMS+PrEP and non-DREAMS comparison sites, and retention of YWSS
over the 24-month period. The primary outcome is HIV incidence among YWSS HIV-negative at study enrolment
measured by repeat, rapid HIV testing over 24-months. Inference will be based on plausibility that DREAMS+PrEP had
an impact on HIV incidence. A process evaluation will be conducted to understand intervention implementation, and
document any contextual factors determining the success or failure of intervention delivery.
Discussion: HIV prevention products of known efficacy are available. Innovative studies are needed to provide
evidence of how to optimise product use through combination interventions to achieve population impact within
different contexts. We describe the design of such a study.
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Background
In public health, one aim of implementation science
studies, including impact evaluations, is to understand
whether and how interventions with known efficacy
should be delivered to have a population-level impact in
real-life settings. Interventions supporting delivery are
often complex, taking the form of a package of strategies
to support demand for, use and adherence to prevention
behaviours and/or technologies. Contextual adaptation
for effective delivery may be critical to achieve impact.
Randomised allocation may not be feasible in some set-
tings, posing challenges to such studies. Implementation
science studies therefore require innovation in study de-
sign, and pre-published protocols for these studies are
particularly important yet less commonly published than
for randomised trials.
In this protocol paper, we describe the evaluation of a
complex and ambitious intervention package being de-
livered by multiple providers with the aim of reducing
HIV infection rates among high-risk young women in
Zimbabwe. We outline challenges faced in designing a
rigorous study to estimate the impact of the intervention
in this situation, and describe our proposed design, ana-
lysis strategy and approach to inference.
Across sub-Saharan Africa, adolescent girls and
young women (AGYW) are at disproportionately
higher risk of HIV than older females and their male
peers [1, 2]. This increased risk is driven by a combin-
ation of biological, behavioural and structural factors
[3]. At highest risk of infection are young female sex
workers (FSW) and other young women who sell sex
(YWSS) for financial or material resources [4]. Relative
to older FSW, young FSW and YWSS aged under
25 years are at increased risk due to economic vulner-
ability, sexual partnerships with older men more likely
to than younger men to have prevalent infection, and
reduced skills in condom use negotiation [5–8].
Limited access to available health services for fear of
stigma and discrimination further increases their risk
of HIV and other health outcomes [5, 7]. In Zimbabwe,
our experience is that YWSS, those under 25 years as
well as those who have most recently begun sex work,
may not identify as sex workers. Consequently, they are
less likely to access sex work specific services [4, 9]. Youn-
ger FSW are also less frequently recruited to research
studies of FSW [10, 11]. As such, YWSS are particularly
vulnerable to new infection as well as being hidden and
complex to conduct evaluation studies with. We anticipate
that their risk of new HIV infection is very high; our esti-
mates among young FSW suggest an incidence perhaps as
high as 10% per year [9].
In 2015, WHO recommended the use of tenofovir-
based oral pre-exposure prophylaxis (PrEP) for individ-
uals at substantial risk of HIV as part of combination
HIV prevention [12] based on a systematic review of
PrEP studies among a range populations and settings
[13]. The review found that PrEP was effective at redu-
cing HIV risk across sexual exposures, PrEP regimen,
dosing, and mode of acquisition, and that increased ad-
herence was associated with a demonstrable increase in
effectiveness [13]. In trials with adherence > 70%, PrEP
reduced risk of infection by 70% (RR = 0.30, 95% CI:
0.21–0.45, p = 0.001) [13]. While there is no doubt that,
when taken, PrEP is biologically effective in women,
pharmacokinetic studies have indicated lower concentra-
tions of tenofovir in vaginal than rectal tissues [14–16]
suggesting that adherence is particularly important in
women. Evidence from treatment scale-up suggests that
younger people find it more difficult to adhere to treat-
ment than older individuals [17], and may require in-
creased adherence support tailored to their age group
and lifestyle. In settings where PrEP is available, imple-
mentation research is needed to translate the efficacy of
PrEP into population-level impact through increased de-
mand and adherence among those at highest risk of
HIV, including YWSS. To achieve population-level im-
pact, combined strategies that deliver services that are
acceptable and accessible to YWSS, generate demand
for, and support use of and adherence to PrEP should be
considered [8, 18].
The DREAMS (“Determined, Resilient, Empowered,
AIDS-free Mentored, and Safe”) initiative is a package
of HIV prevention interventions that aim to synergis-
tically address social, economic, behavioural and
biological risk factors that place young women at
heightened risk of infection [19, 20]. DREAMS is being
implemented in ten sub-Saharan African countries with
DREAMS aiming to reduce HIV incidence by 40%
among AGYW aged 15–24 years [20]. The package in-
cludes social protection (interventions to support
young women to remain or return to school, or acquire
vocational skills), clinical and prevention services for
gender-based violence (GBV), and HIV prevention
(HIV testing, STI screening and treatment, condoms).
Various providers are implementing these combined in-
terventions in real-world conditions, targeting the most
vulnerable, high-risk AGYW. In some settings, includ-
ing Zimbabwe, PrEP is a component of the package of-
fered to AGYW aged 18 to 24 years at highest risk of
HIV (DREAMS+PrEP). This paper outlines the design
of a non-randomised, study to estimate the impact of
DREAMS+PrEP on HIV incidence among YWSS in
two sites in Zimbabwe and to compare this to incidence
in sites where DREAMS is not available.
The DREAMS+PrEP initiative in Zimbabwe
In Zimbabwe, DREAMS is being delivered in six districts
by seven implementing partners (IP). IP identify young
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women who are eligible and likely to benefit from
DREAMS, determine their needs and refer them to
other IP as appropriate. The route into DREAMS varies
according to the specific focus of the IP, for example,
entry into DREAMS may be through schools, clinics,
HIV testing services or the community more generally.
Through this referral process, DREAMS interventions
can be “layered” dependent on need. DREAMS targets
all vulnerable AGYW aged 10–24 years. In four of the
six DREAMS districts, PrEP is being offered to women
at highest risk of infection aged 18–24 years, particularly
YWSS. PrEP is delivered by PSI Zimbabwe. YWSS are
identified through community outreach and mobilisation
led by The Centre for Sexual Health and HIV/AIDS
Research (CeSHHAR). Community mapping guided the
community outreach to identify hotspots where sex is
exchanged for material resources. Importantly mapping
was not limited to sex work venues.
Network-based recruitment for referral to services and
cohort recruitment
We hypothesise that YWSS exist in sizeable numbers in
the DREAMS sites and that they are inter-connected
through social networks. To identify these young
women, refer them to DREAMS+PrEP services, and re-
cruit them into the impact evaluation study, we will use
a network-based recruitment (RDS) strategy that uses
social networks to identify and recruit eligible women.
At the time of the design of this study, the DREAMS
programme selected the 18–24 age cut-off for PrEP. The
DREAMS target was to initiate 1400 women aged 18–24
on PrEP, of which 80% would be referred from two
DREAMS+PrEP sites. In the two DREAMS+PrEP sites,
PSI will deliver PrEP. To support uptake and adherence
to PrEP, community mobilisation activities, PrEP adher-
ence support groups and peer outreach services will be
specifically targeted to YWSS. Sisters with a Voice
(Sisters) programme, an existing national FSW
programme that offers HIV care and prevention services,
will deliver these services. Initiated in 2009, Sisters pro-
vides HIV targeted services to FSW in 36 sites across
Zimbabwe in line with WHO guidance [4, 9]. The Young
Sisters programme offers services specifically tailored for
younger women aged 15–19 years [4].
The community mapping allowed for the identification
and recruitment of “seeds” to start the network-based
recruitment process (Fig. 1). A “seed” is a participant
purposively selected to start recruitment. Seeds will be
drawn from different ages (between 18 and 24 years),
types of selling sex/exchanging sex for resources and
geographical spread across each site as identified in
community mapping. Each seed will be offered two cou-
pons and asked to recruit two young women who they
think meets the inclusion criteria [21], namely: the
recruit should be a young woman aged 18–24 whom
they know (defined as seeing each other at least once a
month) who also exchanges sex with men for money
and/or resources. Our definition of “selling sex” includes
young women who self-identify as FSW and extends to
young women who have sex with men in exchange for
money and/or resources and report the sex would not
occur in the absence of this exchange (but do not think
of themselves as sex workers). Women receiving a cou-
pon who attend the study site for enrolment (“recruits”)
will also be given two coupons to recruit two peers. In
all impact evaluation sites, six iterations of this process
(“waves”) will be completed to refer YWSS to services
and recruit the sample size required for the impact
evaluation as described below.
Once reached, women attending the study site will be
referred to DREAMS+PrEP interventions dependent on
need and recruited to the impact evaluation. The same
strategy is being implemented in four non-DREAMS
comparison sites, with YWSS referred to the Sisters
programme and/or other appropriate services available
in these sites. Services offered at Sisters clinics include:
STI screening and treatment, HIV testing with referrals
to government services for treatment, free condoms and
contraception, and legal advice supported by a network
of peer educators.
Key considerations for study design
We seek to estimate the impact of the DREAMS+PrEP
intervention on HIV incidence among YWSS aged 18–24.
The DREAMS+PrEP intervention includes identifying
high risk women, referral for an offer of PrEP for those
testing negative, and referral to other DREAMS interven-
tions, depending on need and availability, that will support
use and adherence through a variety of behavioural and
structural interventions. This impact evaluation has four
main design challenges. First, it was not possible to ran-
domise study sites to receive the DREAMS intervention.
DREAMS districts were selected through country-level
consultation and based on population of AGYW and HIV
burden. Second, YWSS, the target group for this evalu-
ation are a “hidden” population for which a sampling
frame does not exist. Third, there are few intervention dis-
tricts, and 80% of the intended beneficiaries that fall
within our target group will be recruited from only two
districts. Fourth, there are numerous providers and the
strategies to identify, reach and refer YWSS to services
is complex.
Our overall approach to these design challenges is to:
1) use existing data (from the Sisters programme) to se-
lect comparison sites comparable to the DREAMS+PrEP
sites in factors known to influence HIV risk; 2) leverage
the use of the network-based (respondent driven) strat-
egy that is being used to identify and reach YWSS, refer
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these YWSS to services, in order to recruit them into
the impact evaluation, and repeat this process in the
non-DREAMS comparison sites; 3) take a cohort ana-
lysis approach to compare HIV incidence among YWSS
in the DREAMS+PrEP sites with YWSS in the non-
DREAMS comparison sites, and collect data on recent
infection and risk factors for HIV incidence at enrol-
ment in support of an adjusted analysis; 4) embed a
process evaluation within the impact evaluation to seek
to understand intervention implementation, and docu-
ment any contextual factors determining the success or
failure of delivery of intervention components.
Methods
Study location and non-randomised site selection
We will conduct this study in two DREAMS+PrEP and
four non-DREAMS comparison sites. We selected the
two DREAMS+PrEP sites, as these sites will refer the
largest proportion of young women to PrEP and
supportive interventions. These two sites are cities,
among the largest in Zimbabwe, with a combined popu-
lation of over 500,000. Each site has a static Sisters
programme clinic that offers walk-in clinical services
Monday to Friday each week [9].
We selected comparison sites from the 36 sites where
the Sisters programme is operational [9]. Of the 36 na-
tional Sisters sites, six are static sites in larger towns and
cities that provide walk-in services on weekdays and 30
are mobile sites in smaller towns where outreach ser-
vices are delivered weekly. From the Sisters sites, we first
excluded sites that overlapped with DREAMS, excluded
seven sites where an HIV treatment and prevention, in-
cluding PrEP, intervention trial (SAPPH-Ire trial) had
been implemented [17], and a site where another organ-
isation is delivering PrEP. Second, we excluded 15 rural
sites. From the remaining eight urban sites, we selected
four comparison sites using routine Sisters programme
data and expert opinion. We selected one site as it is a
Fig. 1 Schematic of the processes involved in this study to identify, reach and refer young women who sell sex to services and recruit these
same women into an impact evaluation cohort
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large town with a static Sisters clinic where > 1500 FSW
were registered by mid-2016, of whom 25% were aged
18 to 24. Of the remaining seven sites we selected three
sites because they each had: 1) > 400 FSW registered
with the programme; 2) among whom > 20% were aged
18–24, and 3) each site was a similar distance to Harare
as the two DREAMS+PrEP sites.
Measurements and sample collection
Young women recruited to the impact evaluation study
will be asked to provide written consent to complete a
questionnaire, provide a dried blood spot (DBS) and
have a rapid HIV test. Women will be followed-up at 12
and 24 months, and asked to complete an interviewer-
administered questionnaire and offered HIV testing ser-
vices using a rapid HIV test-kit. The questionnaire will
cover socio-demographic factors, a range of behavioural
characteristics, access to health and/or social-support
services, and HIV-related questions. We will use the
DBS collected at enrolment to test for HIV, and, for
those who test HIV-positive, to determine prevalence of
recent infection using Recent Infection Testing Algo-
rithm (RITA), which includes use of the LAG avidity
assay coupled with viral load testing.
Retention and follow-up procedures
To assist with retention of the cohort, women will be
asked to provide their phone number and residential in-
formation, and informed that the information will be used
to send follow-up reminders via WhatsApp® or through
home visits 12- and 24-months after enrolment. We will
exclude young women who report that they are planning
to move away from the district within the next six months.
Locator information will be checked for completeness and
accuracy at each visit. To support retention in the
programme, curated WhatsApp® broadcast groups of ap-
proximately 50 participants each will be developed. The
curator will send messages but the broadcasts will not dis-
close who is in the group or share any phone numbers.
Primary outcome measurement
The primary outcome is HIV incidence over the
24 months following enrolment into the study, the nu-
merator will be the number of new infections among
young women testing HIV-negative at enrolment, the
denominator the person-years of follow-up. Person-years
of follow-up for each YWSS will be calculated as: 1) time
between the first HIV negative test at enrolment and an
HIV negative test at 12 months and 24 months; or 2)
the mid-point between an HIV negative test and an HIV
positive test. If a participant is lost to follow-up (LTFU),
the participant will be censored at last HIV-negative test.
Secondary outcomes
This study has many secondary outcomes, including re-
duced food insecurity, reduced condom-less sex with
sexual partners, reduced experience of violence from
partners and police, reduced reliance on sex work for
economic reasons, increased uptake of HIV testing ser-
vices and access to STI treatment services, and self-
reported adherence to ART or PrEP.
Ethical approval
We received ethical approval for this study from the
Medical Research Council of Zimbabwe (Reference
number MRCZ/A/2085) and the London School of Hy-
giene and Tropical Medicine (Reference number 11835).
Statistical analysis
We aim to adhere to the transparent reporting principles
of TREND [22]. In addition, we will report on items es-
sential to the network-based (RDS) recruitment as per
the STROBE-RDS extension [23]. We will finalise a stat-
istical analysis plan before data collection at 24-months
is complete.
Cohort profile
Using data collected at enrolment, we will describe non-
participation among women recruited to the study (ineli-
gible, non-consent, declined to recruit others), the range
and mean size of the sample recruited through the
network-based (RDS) strategy, and present recruitment
trees by site. We will describe unweighted characteristics
of study participants and describe the number with
missing data for the outcomes as recommended by the
STROBE-RDS extension [24]. Although we cannot
present non-participation among women not attending
study sites, we will describe the mean and range of
women who did not recruit peers by site and ask women
recruited into the study to estimate how many women
they tried to recruit but who refused. We will report any
recruitment challenges in line with the STROBE-RDS
extension [24].
RDS diagnostics
Our analysis will account for the network (RDS)-based
recruitment strategy. We (JH, FC) previously described
our approach to analysis of RDS data and diagnostics to
assess whether there is evidence that the sample deviates
from the assumptions made by the RDS-2 estimation
[21, 25, 26]. Similar diagnostics will be performed for
this study using data collected in the questionnaire
among all women and a brief follow-up interview among
women collecting recruitment incentives to assess
whether our sample deviates from RDS-2 assumptions
and whether any deviation differs by the intervention
and comparison groups, which would have implications
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for our findings [21]. Using enrolment data, a diagnos-
tics will include: exploring whether the cumulative esti-
mate of our primary and secondary outcomes stabilise
over time from “seed” characteristics, and whether esti-
mates from each seed converge [21, 27]. We will assess
the assumption that participants are able to accurately
report their network size and randomly recruit from
within this network using data on network asked size
both in the main interview and in the follow-up inter-
view among participants collecting secondary incentives
for recruiting peers to the study (although half the women
will not receive secondary incentives once sample size).
We will conduct a test-retest reliability of this estimate;
assessing the proportion of women who, at the point of
enrolment, report that a stranger gave them the recruit-
ment voucher.
Assessing balance across sites
Using enrolment data, we will describe characteristics of
the YWSS recruited into the DREAMS+PrEP and non-
DREAMS comparison cohorts. To assess whether there
is any imbalance across the two cohorts in risk factors
for HIV, we will conduct a comparative analysis of the
socio-demographic characteristics, sexual behaviours of
the YWSS recruited to the impact evaluation, and preva-
lent and recent infection. Where there is evidence of im-
balance in factors likely to influence HIV risk, we will
adjust for these individual-level factors in our analysis of
the primary outcome as described below.
Stages of primary outcome analysis
We will adopt a transparent and simple cohort approach
to the analysis of the primary outcome. Our approach to
inference will consider whether it is plausible that
DREAMS+PrEP had an impact on HIV incidence among
the target population [28, 29].
We will conduct our primary analysis in three phases.
Each stage aims to build the strength of the evidence
base of a plausible causal impact of DREAMS on HIV
incidence. In phase one, we will take an individual-level
cohort analysis approach. At 24-months, we will de-
scribe the number of women retained in the cohort and
summarise follow-up time (average and total) in the
DREAMS+PrEP and comparison sites. We will describe
HIV incidence at 24 months in the DREAMS+PrEP and
comparison groups with associated 95%CI. We will also
describe site-specific estimates of incidence. Using
Poisson regression, we will compare the incidence rates
at 24-months across the two groups expressed as an un-
adjusted rate ratio with associated 95%CI presented. To
account for the RDS design, we will weight the data by
1/self-reported degree of social network.
The unadjusted rate ratio is subject to confounding by
risk factors for HIV that are differential across the two
groups in the absence of random allocation and the
small number of sites. In phase two, we will estimate a
rate ratio adjusted for potential confounders. We will
present the adjusted rate ratio with associated 95%CI.
In the third phase, we will assess whether there is evi-
dence for an association between individual-level expos-
ure to DREAMS+PrEP interventions and HIV incidence.
For example, we will compare the risk of HIV infection
between women self-reporting that they are adherent to
PrEP and women who did not take PrEP. We will specify
the exact measures of exposure after the year 1 data
have been collected, without reference to the outcome
data and before the final follow-up.
Sample size justification
DREAMS aims to reduce HIV incidence among AGYW
by 40%. In the absence of a robust estimate of HIV inci-
dence among the target population, we used data from
the Sisters programme and the MTN-020 Dapivirine
vaginal ring trial to determine the required sample size
[9, 30]. A cohort analysis of Sisters programmatic data
estimated that HIV incidence was 10.8% (95%CI: 8.1–
16.1) among FSW aged 18–25 years [9]. In the ASPIRE
trial, HIV incidence among women aged 18 to 45 was
4.5 per 100 person-years in the placebo arm, 6.2 per 100
person years in the placebo arms in South Africa, 2.6 in
Malawi, Uganda and Zimbabwe [30]. Relative to the tar-
get population in our study, women in the ASPIRE trial
might have been at lower risk of HIV, with only 7%
reporting transactional sex in the previous year. Based
on these estimates and assuming individual-level ana-
lysis, we assume that incidence among YWSS in the ab-
sence of DREAMS+PrEP is between 5.0 and 8.0 new
infections per 100 person-years. We also anticipate that,
at the point of enrolment, 20% of YWSS will test HIV
positive and that 30% of YWSS will be LTFU over the 24-
month period. Based on these estimates, we will recruit
1200 YWSS in the DREAMS+PrEP sites and 1200 in non-
DREAMS sites to have sufficient person-years of follow-
up to have 80% power to detect a reduction of 40% or
more in incidence after 24-months at the p = 0.05 level
(Table 1).
Process evaluation
Embedded within the impact evaluation is a process
evaluation that will compile routine programme data
and conduct qualitative research to assess the fidelity,
acceptability, and feasibility of the DREAMS+PrEP pack-
age. The process evaluation framework is designed to ac-
company the assumed pathway of the intervention
(Fig. 2). The aim of the process evaluation is to
strengthen the plausibility that any apparent effect is at-
tributable to the DREAMS combined package.
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Methods
To determine fidelity, interviews with staff across
DREAMS providers will examine whether the programme
components were delivered as intended and identify chal-
lenges, delays, or omissions in planned implementation.
We will also conduct in-depth interviews at the time of
the network-based recruitment with five “seeds” in each of
the two DREAMS+PrEP and two non-DREAMS sites to
discuss issues relevant to the hypothesised causal pathway.
In-depth interviews will also be conducted in these four
sites with a cross-section of twenty-four (n = 24) partici-
pants every six-months, purposively sampled according to
age and levels of uptake of different DREAMS+PrEP inter-
vention or Sisters programme components. Twice a year,
participatory evaluation workshops will be conducted with
YWSS engaged in DREAMS+PrEP to elucidate their per-
ceptions of the quality and usefulness of different aspects
of the programme. Records of outreach contacts, activity
attendance and referrals between implementing partners
will be analysed to assess the number of DREAMS
services that YWSS access, and with what frequency.
Finally, a smaller cohort of YWSS will be prospect-
ively followed through repeat interviews and audio
diaries (n = 12) to explore dimensions of their lives
targeted by DREAMS, namely empowerment, financial
literacy, personal aspirations, and sexual behaviour
and health at individual level, and social support and
peer norms at community level.
Discussion
Estimating the population-level impact of the combined
package of interventions delivered through DREAMS on
HIV incidence presents numerous challenges, including
non-random allocation of DREAMS to a small number
Table 1 Study power to detect a 30–50% reduction in HIV incidence in DREAMS+PrEP cohort compared to incidence in a
comparison cohort with at least 690 YWSS followed up over 24 months (1500–1380 person-years follow-up/cohort)
HIV incidence in
comparison cohort
Reduction in HIV incidence in DREAMS+PrEP cohort
50% 40% 30% 50% 40% 30%
1500pyrs follow-up per cohort 1380pyrs follow-up per cohort
5.0 94 77 49 92 75 46
6.0 96 85 59 96 82 55
7.0 98 90 66 98 87 62
8.0 99 93 72 99 91 67
Fig. 2 Hypothesised causal pathway of the DREAMS+PrEP package of interventions on HIV incidence
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of sites, the lack of sampling frame for the target popula-
tion and high number of service providers. In response,
we sought to design a robust study and analysis strategy
to allow us to infer whether DREAMS+PrEP has an im-
pact on HIV incidence among YWSS in Zimbabwe. We
designed a non-randomised prospective study, that uses
a network-based (RDS) recruitment strategy and adopts
a cohort analysis approach to compare HIV incidence
among cohorts of YWSS recruited in DREAMS+PrEP
and non-DREAMS sites.
Nonetheless, our study has limitations. There is no
sampling frame for the target population for the evalu-
ation. Our decision to use the same network (RDS)-
based strategy attempts to ensure that the populations
recruited in the DREAMS+PrEP and non-DREAMS
comparison groups are comparable. First proposed in
1997 [31, 32], the use of RDS surveys has become in-
creasingly popular [32]. In parallel, statistical techniques
for the analysis of RDS data has evolved to allow for less
biased estimation [25]. More recently, studies have used
RDS to recruit and follow-up a cohort of individuals,
primarily among men who have sex with men [33–36].
Our study team has substantial experience conducting
RDS surveys among FSW [10, 11, 21]. Although ap-
proximately 30% of FSW recruited to these surveys have
been aged 18–24 [10, 11], this study is recruiting a
broader population of young women, including those
who do not self-identify as FSW.
We recognise that retention of the YWSS recruited
into the cohorts may prove challenging, as such our
sample size calculations assume a 30% LTFU over the
24-month study. Furthermore, individuals LTFU may
differ in the two groups, leading to bias estimates of
HIV incidence. We opted for a cohort design rather than
repeat cross-sectional surveys as we are interested in the
impact of DREAMS+PrEP among YWSS referred to and
offered DREAMS+PrEP services. We recognise that both
design options have limitations. Repeat cross-sectional
surveys, however, would suffer from issues of temporal-
ity, we would not be able to explore individual-level
changes over time, and women recruited at successive
surveys may have had no exposure to DREAMS+PrEP.
Through our cohort study design, YWSS will be referred
to and offered DREAMS+PrEP services dependent on
need. Our study will therefore allow us to understand
women’s level of engagement and reasons for non-
engagement with DREAMS.
The DREAMS package of interventions aims to reduce
HIV incidence by 40% among AGYW. As such, our
study is powered to detect a 40% difference in HIV be-
tween the DREAMS+PrEP and non-DREAMS compari-
son cohorts. This is a large reduction in incidence. If
DREAMS+PrEP reduces incidence by 40% we may be
able to detect this difference, if levels of LTFU and HIV
prevalence at enrolment are as hypothesised, but reduc-
tions lower than 40% may not be detected with the
proposed sample size. PrEP efficacy studies have shown
up to 67% reduction in HIV among sero-discordant cou-
ples and young men and women in sub-Saharan Africa
[1, 37, 38]. Sub-group analyses suggest efficacy is higher
with increased levels of adherence [1, 37]. An offer of
PrEP alongside interventions to support retention in or
return to school, and improve access to HIV testing, STI
screening and treatment among other services are likely
to have a large impact on these women’s lives, their ac-
cess to services and their risk of HIV infection. Should
this study be underpowered, it can still provide evidence
critical to understanding whether and how DREAMS
+PrEP changed young women’s lives and to informing
how to provide this underserved and vulnerable popula-
tion with access to HIV prevention and care services
within a broader social support package.
Interventions for the prevention of HIV are now avail-
able, including PrEP and condoms [18, 39]. Since 2010,
there have been declines in HIV incidence many coun-
tries, yet young women aged 15–24 years remain at dis-
proportionately high risk, accounting for 20% of new
infections [2]. In sub-Saharan Africa, young women
accounted for 25% of new adult HIV infections in 2015
[2] Implementation science research is required to iden-
tify how best to optimise delivery of these prevention in-
terventions in different settings [18, 40]. Optimal
delivery is not straightforward, requiring the implemen-
tation of multiple interventions to increase demand,
achieve acceptable and accessible supply, and overcome
barriers to adherence and use, including socioeconomic
barriers [18, 39]. Contextual factors that influence opti-
mal delivery also need to be considered. In order to
maximise population impact, implementation research
should focus on how to deliver such complex interven-
tions to those AGYW who are at highest risk of HIV in-
fection and hardest to reach with prevention and care
programmes [4]. We have described the approach we
have taken to evaluate the DREAMS+PrEP intervention
among young women at highest risk in Zimbabwe.
Transparency with regards to design considerations for
evaluating complex prevention programmes in real
world settings is critical to maximise our understanding
of how best to bring such interventions to scale
effectively.
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